NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.[ Read More ]
The intrinsic value of one NVCR stock under the base case scenario is HIDDEN Compared to the current market price of 16.1 USD, NovoCure Limited is HIDDEN
Current Assets | 1.03 B |
Cash & Short-Term Investments | 911 M |
Receivables | 61.2 M |
Other Current Assets | 62.6 M |
Non-Current Assets | 112 M |
Long-Term Investments | 0 |
PP&E | 97.7 M |
Other Non-Current Assets | 14 M |
Current Liabilities | 179 M |
Accounts Payable | 94.4 M |
Short-Term Debt | 0 |
Other Current Liabilities | 84.7 M |
Non-Current Liabilities | 605 M |
Long-Term Debt | 596 M |
Other Non-Current Liabilities | 8.28 M |
Revenue | 509 M |
Cost Of Revenue | 128 M |
Gross Profit | 381 M |
Operating Expenses | 614 M |
Operating Income | -233 M |
Other Expenses | -25.8 M |
Net Income | -207 M |
Net Income | -207 M |
Depreciation & Amortization | 11 M |
Capital Expenditures | -27.1 M |
Stock-Based Compensation | 116 M |
Change in Working Capital | 29.6 M |
Others | -28.2 M |
Free Cash Flow | -100 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
2 weeks ago
Nov 02, 2024
|
Sell 734 USD
|
Paravasthu Mukund
Chief Operating Officer |
- 44
|
16.6858 USD |
2 weeks ago
Oct 31, 2024
|
Sell 12.8 K USD
|
Puri Michal Nath
Chief Human Resources Officer |
- 810
|
15.7922 USD |
2 weeks ago
Nov 01, 2024
|
Sell 9.53 K USD
|
Leonard Frank X
EVP, Pres., Novocure Oncology |
- 598
|
15.9377 USD |
2 weeks ago
Nov 01, 2024
|
Sell 2.54 K USD
|
Paravasthu Mukund
Chief Operating Officer |
- 160
|
15.8776 USD |
3 months ago
Aug 02, 2024
|
Sell 13.9 K USD
|
Cordova Ashley
Chief Financial Officer |
- 688
|
20.1416 USD |
5 months ago
Jun 04, 2024
|
Sell 23 K USD
|
VERNON W ANTHONY
Director |
- 964
|
23.893 USD |
5 months ago
Jun 04, 2024
|
Sell 23 K USD
|
Scannell Timothy J
Director |
- 964
|
23.8874 USD |
5 months ago
Jun 04, 2024
|
Sell 23 K USD
|
LEUNG GABRIEL
Director |
- 964
|
23.8851 USD |
8 months ago
Mar 01, 2024
|
Sell 33.8 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 2107
|
16.0269 USD |
8 months ago
Mar 04, 2024
|
Sell 19.5 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 1217
|
16.01 USD |
8 months ago
Mar 01, 2024
|
Sell 26.9 K USD
|
Leonard Frank X
EVP, Pres., Novocure Oncology |
- 1679
|
16.0269 USD |
8 months ago
Mar 04, 2024
|
Sell 13.4 K USD
|
Leonard Frank X
EVP, Pres., Novocure Oncology |
- 840
|
16.01 USD |
8 months ago
Feb 28, 2024
|
Sell 33.5 K USD
|
Leonard Frank X
EVP, Pres., Novocure Oncology |
- 2078
|
16.1428 USD |
8 months ago
Feb 28, 2024
|
Sell 37.2 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 2303
|
16.1428 USD |
1 year ago
Nov 07, 2023
|
Sell 4.83 K USD
|
Shah Pritesh
Chief Growth Officer |
- 382
|
12.65 USD |
1 year ago
Sep 01, 2023
|
Sell 19.3 K USD
|
Cordova Ashley
Chief Financial Officer |
- 883
|
21.8172 USD |
1 year ago
Sep 01, 2023
|
Sell 6.41 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 294
|
21.8172 USD |
1 year ago
Sep 01, 2023
|
Sell 5.96 K USD
|
Shah Pritesh
Chief Growth Officer |
- 273
|
21.8172 USD |
1 year ago
Aug 02, 2023
|
Sell 34.6 K USD
|
Cordova Ashley
Chief Financial Officer |
- 1144
|
30.2511 USD |
1 year ago
Mar 03, 2023
|
Sell 335 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 4403
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 67.6 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 888
|
76.1594 USD |
1 year ago
Mar 07, 2023
|
Sell 450 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 6003
|
74.9968 USD |
1 year ago
Mar 07, 2023
|
Sell 175 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 2315
|
75.5937 USD |
1 year ago
Mar 03, 2023
|
Sell 120 K USD
|
Shah Pritesh
Chief Growth Officer |
- 1570
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 224 K USD
|
Shah Pritesh
Chief Growth Officer |
- 2942
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 1.29 M USD
|
Shah Pritesh
Chief Growth Officer |
- 16909
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 269 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 3528
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 129 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 1692
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 1.55 M USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 20415
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 360 K USD
|
Cordova Ashley
Chief Financial Officer |
- 4730
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 59 K USD
|
Cordova Ashley
Chief Financial Officer |
- 775
|
76.1594 USD |
1 year ago
Mar 03, 2023
|
Sell 45.2 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 593
|
76.1594 USD |
1 year ago
Mar 02, 2023
|
Sell 21.2 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 281
|
75.2779 USD |
1 year ago
Mar 02, 2023
|
Sell 70.5 K USD
|
Shah Pritesh
Chief Growth Officer |
- 937
|
75.2779 USD |
1 year ago
Mar 02, 2023
|
Sell 91.3 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 1213
|
75.2779 USD |
1 year ago
Mar 02, 2023
|
Sell 79.4 K USD
|
Cordova Ashley
Chief Financial Officer |
- 1055
|
75.2779 USD |
1 year ago
Mar 03, 2023
|
Sell 160 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 2059
|
77.6391 USD |
1 year ago
Mar 02, 2023
|
Sell 63.5 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 844
|
75.2779 USD |
1 year ago
Mar 02, 2023
|
Sell 286 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 3799
|
75.3235 USD |
1 year ago
Mar 02, 2023
|
Sell 23.4 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 308
|
76.0511 USD |
1 year ago
Mar 01, 2023
|
Sell 129 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 1684
|
76.3624 USD |
1 year ago
Mar 01, 2023
|
Sell 147 K USD
|
Shah Pritesh
Chief Growth Officer |
- 1923
|
76.3624 USD |
1 year ago
Mar 01, 2023
|
Sell 168 K USD
|
Cordova Ashley
Chief Financial Officer |
- 2198
|
76.3624 USD |
1 year ago
Mar 01, 2023
|
Sell 57.7 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 755
|
76.3624 USD |
1 year ago
Mar 01, 2023
|
Sell 165 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 2164
|
76.3624 USD |
1 year ago
Jan 05, 2023
|
Sell 234 K USD
|
Weinberg Uri
Chief Science Officer |
- 1946
|
120 USD |
1 year ago
Jan 05, 2023
|
Sell 283 K USD
|
Weinberg Uri
Chief Science Officer |
- 2617
|
108 USD |
1 year ago
Jan 05, 2023
|
Sell 144 K USD
|
Weinberg Uri
Chief Science Officer |
- 1201
|
120 USD |
1 year ago
Jan 05, 2023
|
Sell 279 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 2345
|
119.0077 USD |
1 year ago
Jan 05, 2023
|
Sell 45 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 417
|
108 USD |
1 year ago
Jan 05, 2023
|
Sell 60.5 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 526
|
115.0348 USD |
1 year ago
Jan 05, 2023
|
Sell 862 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 7183
|
120 USD |
1 year ago
Jan 05, 2023
|
Sell 41.8 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 387
|
108 USD |
1 year ago
Jan 05, 2023
|
Sell 931 K USD
|
Danziger Asaf
Chief Executive Officer |
- 8369
|
111.2338 USD |
1 year ago
Jan 05, 2023
|
Sell 226 K USD
|
Danziger Asaf
Chief Executive Officer |
- 2000
|
112.8632 USD |
1 year ago
Jan 05, 2023
|
Sell 522 K USD
|
Danziger Asaf
Chief Executive Officer |
- 4568
|
114.3524 USD |
1 year ago
Jan 05, 2023
|
Sell 427 K USD
|
Danziger Asaf
Chief Executive Officer |
- 3702
|
115.2113 USD |
1 year ago
Jan 05, 2023
|
Sell 162 K USD
|
Danziger Asaf
Chief Executive Officer |
- 1395
|
116.0618 USD |
1 year ago
Jan 05, 2023
|
Sell 117 K USD
|
Danziger Asaf
Chief Executive Officer |
- 999
|
117.0111 USD |
1 year ago
Jan 05, 2023
|
Sell 252 K USD
|
Danziger Asaf
Chief Executive Officer |
- 2123
|
118.4714 USD |
1 year ago
Jan 05, 2023
|
Sell 160 K USD
|
Danziger Asaf
Chief Executive Officer |
- 1344
|
119.3493 USD |
1 year ago
Jan 05, 2023
|
Sell 20.2 M USD
|
Danziger Asaf
Chief Executive Officer |
- 187500
|
108 USD |
2 years ago
Oct 13, 2022
|
Sell 513 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 6754
|
76.01 USD |
2 years ago
Oct 06, 2022
|
Sell 570 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 6754
|
84.37 USD |
2 years ago
Sep 29, 2022
|
Sell 522 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 6754
|
77.35 USD |
2 years ago
Sep 22, 2022
|
Sell 520 K USD
|
Leonard Frank X
President, CNS Cancers US |
- 6754
|
77 USD |
2 years ago
Sep 15, 2022
|
Sell 590 K USD
|
Leonard Frank X
Chief Development Officer |
- 6754
|
87.31 USD |
2 years ago
Sep 15, 2022
|
Sell 497 K USD
|
Leonard Frank X
Chief Development Officer |
- 5517
|
90 USD |
2 years ago
Sep 08, 2022
|
Sell 550 K USD
|
Leonard Frank X
Chief Development Officer |
- 6754
|
81.48 USD |
2 years ago
Sep 09, 2022
|
Sell 164 K USD
|
Leonard Frank X
Chief Development Officer |
- 1863
|
88 USD |
2 years ago
Sep 06, 2022
|
Sell 109 K USD
|
Leonard Frank X
Chief Development Officer |
- 1384
|
78.57 USD |
2 years ago
Sep 02, 2022
|
Sell 56.7 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 718
|
79.037 USD |
2 years ago
Sep 02, 2022
|
Sell 69.9 K USD
|
Cordova Ashley
Chief Financial Officer |
- 885
|
79.037 USD |
2 years ago
Sep 02, 2022
|
Sell 23.4 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 296
|
79.037 USD |
2 years ago
Sep 02, 2022
|
Sell 21.3 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 269
|
79.037 USD |
2 years ago
Sep 01, 2022
|
Sell 135 K USD
|
Leonard Frank X
Chief Development Officer |
- 1750
|
76.958 USD |
2 years ago
Aug 03, 2022
|
Sell 40 K USD
|
Benaim Ely
Chief Medical Officer |
- 563
|
71.09 USD |
2 years ago
Aug 03, 2022
|
Sell 399 K USD
|
Benaim Ely
Chief Medical Officer |
- 5396
|
74 USD |
2 years ago
Aug 02, 2022
|
Sell 58.3 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 837
|
69.659 USD |
2 years ago
Aug 02, 2022
|
Sell 30.4 K USD
|
Benaim Ely
Chief Medical Officer |
- 437
|
69.659 USD |
2 years ago
Aug 02, 2022
|
Sell 28.8 K USD
|
Leonard Frank X
Chief Development Officer |
- 414
|
69.659 USD |
2 years ago
Jun 10, 2022
|
Sell 28.3 K USD
|
HILLEMAN JERYL L
director: |
- 407
|
69.61 USD |
2 years ago
May 10, 2022
|
Sell 135 K USD
|
Benaim Ely
Chief Medical Officer |
- 2070
|
65.158 USD |
2 years ago
May 10, 2022
|
Sell 131 K USD
|
Benaim Ely
Chief Medical Officer |
- 2135
|
61.25 USD |
2 years ago
Mar 09, 2022
|
Sell 261 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 3669
|
71.19 USD |
2 years ago
Mar 07, 2022
|
Sell 174 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 2481
|
70.1 USD |
2 years ago
Mar 08, 2022
|
Sell 52.2 K USD
|
Leonard Frank X
Chief Development Officer |
- 744
|
70.1 USD |
2 years ago
Mar 08, 2022
|
Sell 72.7 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 1037
|
70.1 USD |
2 years ago
Mar 08, 2022
|
Sell 205 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 2923
|
70.1 USD |
2 years ago
Mar 08, 2022
|
Sell 53.2 K USD
|
Cordova Ashley
Chief Financial Officer |
- 759
|
70.1 USD |
2 years ago
Mar 08, 2022
|
Sell 164 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2339
|
70.1 USD |
2 years ago
Mar 08, 2022
|
Sell 167 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 2385
|
70.1 USD |
2 years ago
Mar 03, 2022
|
Sell 81.5 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1094
|
74.498 USD |
2 years ago
Mar 03, 2022
|
Sell 39.1 K USD
|
Cordova Ashley
Chief Financial Officer |
- 556
|
70.407 USD |
2 years ago
Mar 03, 2022
|
Sell 135 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 1914
|
70.407 USD |
2 years ago
Mar 03, 2022
|
Sell 59.8 K USD
|
Benaim Ely
Chief Medical Officer |
- 803
|
74.498 USD |
2 years ago
Mar 03, 2022
|
Sell 106 K USD
|
Benaim Ely
Chief Medical Officer |
- 1510
|
70.407 USD |
2 years ago
Mar 03, 2022
|
Sell 72.2 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 1026
|
70.407 USD |
2 years ago
Mar 03, 2022
|
Sell 96.9 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 1301
|
74.498 USD |
2 years ago
Mar 03, 2022
|
Sell 181 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 2569
|
70.407 USD |
2 years ago
Mar 03, 2022
|
Sell 39.1 K USD
|
Leonard Frank X
Chief Development Officer |
- 555
|
70.407 USD |
2 years ago
Jan 03, 2022
|
Sell 30.3 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 399
|
76.03 USD |
2 years ago
Jan 03, 2022
|
Sell 69.9 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 919
|
76.087 USD |
2 years ago
Jan 03, 2022
|
Sell 200 K USD
|
Burke William Patrick
Chief Human Resources Officer |
- 2633
|
75.96 USD |
2 years ago
Nov 26, 2021
|
Bought 10 K USD
|
Danziger Asaf
Chief Executive Officer |
+ 104
|
96.5 USD |
2 years ago
Nov 26, 2021
|
Bought 103 K USD
|
Danziger Asaf
Chief Executive Officer |
+ 1000
|
103.37 USD |
2 years ago
Nov 26, 2021
|
Bought 396 K USD
|
Danziger Asaf
Chief Executive Officer |
+ 3870
|
102.36 USD |
3 years ago
Nov 02, 2021
|
Sell 22.4 K USD
|
Cordova Ashley
Chief Financial Officer |
- 209
|
107.276 USD |
3 years ago
Sep 02, 2021
|
Sell 74.6 K USD
|
Leonard Frank X
Chief Development Officer |
- 540
|
138.232 USD |
3 years ago
Sep 02, 2021
|
Sell 114 K USD
|
Cordova Ashley
Chief Financial Officer |
- 828
|
138.232 USD |
3 years ago
Sep 02, 2021
|
Sell 25 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 181
|
138.232 USD |
3 years ago
Sep 02, 2021
|
Sell 21.6 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 156
|
138.232 USD |
3 years ago
Sep 03, 2021
|
Sell 44.4 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 321
|
138.273 USD |
3 years ago
Sep 03, 2021
|
Sell 20.9 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 150
|
139.238 USD |
3 years ago
Sep 03, 2021
|
Sell 4.21 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 30
|
140.18 USD |
3 years ago
Aug 12, 2021
|
Sell 836 K USD
|
Cordova Ashley
Chief Financial Officer |
- 5927
|
141.06 USD |
3 years ago
Aug 12, 2021
|
Sell 1.13 M USD
|
Cordova Ashley
Chief Financial Officer |
- 8026
|
140.902 USD |
3 years ago
Aug 12, 2021
|
Sell 367 K USD
|
Cordova Ashley
Chief Financial Officer |
- 2606
|
140.9 USD |
3 years ago
Aug 05, 2021
|
Sell 5.21 K USD
|
Madden Martin J.
Director |
- 34
|
153.13 USD |
3 years ago
Aug 04, 2021
|
Sell 307 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 2063
|
148.71 USD |
3 years ago
Aug 05, 2021
|
Sell 152 K USD
|
LEUNG GABRIEL
Director |
- 1000
|
152.5 USD |
3 years ago
Aug 02, 2021
|
Sell 107 K USD
|
Leonard Frank X
Chief Development Officer |
- 713
|
149.378 USD |
3 years ago
Aug 03, 2021
|
Sell 49 K USD
|
Leonard Frank X
Chief Development Officer |
- 328
|
149.43 USD |
3 years ago
Aug 03, 2021
|
Sell 247 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 1654
|
149.43 USD |
3 years ago
Aug 02, 2021
|
Sell 149 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 995
|
149.378 USD |
3 years ago
Aug 03, 2021
|
Sell 69.7 K USD
|
Benaim Ely
Chief Medical Officer |
- 464
|
150.11 USD |
3 years ago
Jul 30, 2021
|
Sell 103 K USD
|
Benaim Ely
Chief Medical Officer |
- 651
|
158.96 USD |
3 years ago
Aug 02, 2021
|
Sell 80.1 K USD
|
Benaim Ely
Chief Medical Officer |
- 536
|
149.378 USD |
3 years ago
Jul 06, 2021
|
Sell 184 K USD
|
LEUNG GABRIEL
Director |
- 1000
|
183.54 USD |
3 years ago
Jun 10, 2021
|
Sell 5.06 M USD
|
Shah Pritesh
Chief Commercial Officer |
- 23540
|
215 USD |
3 years ago
Jun 07, 2021
|
Sell 205 K USD
|
LEUNG GABRIEL
Director |
- 1000
|
204.55 USD |
3 years ago
May 27, 2021
|
Sell 367 K USD
|
Benaim Ely
Chief Medical Officer |
- 1833
|
200 USD |
3 years ago
May 12, 2021
|
Sell 351 K USD
|
Benaim Ely
Chief Medical Officer |
- 1943
|
180.48 USD |
3 years ago
May 10, 2021
|
Sell 348 K USD
|
Benaim Ely
Chief Medical Officer |
- 1833
|
189.65 USD |
3 years ago
May 11, 2021
|
Sell 407 K USD
|
Benaim Ely
Chief Medical Officer |
- 2262
|
180.118 USD |
3 years ago
May 10, 2021
|
Sell 729 K USD
|
Weinberg Uri
Chief Science Officer |
- 3846
|
189.65 USD |
3 years ago
May 10, 2021
|
Sell 342 K USD
|
Weinberg Uri
Chief Science Officer |
- 1804
|
189.65 USD |
3 years ago
May 05, 2021
|
Sell 258 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 1290
|
199.67 USD |
3 years ago
May 05, 2021
|
Sell 200 K USD
|
LEUNG GABRIEL
Director |
- 1000
|
199.67 USD |
3 years ago
May 04, 2021
|
Sell 209 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 1043
|
200.856 USD |
3 years ago
Apr 13, 2021
|
Sell 268 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1400
|
191.263 USD |
3 years ago
Apr 13, 2021
|
Sell 366 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1900
|
192.524 USD |
3 years ago
Apr 13, 2021
|
Sell 405 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 2090
|
193.571 USD |
3 years ago
Apr 13, 2021
|
Sell 312 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1600
|
194.94 USD |
3 years ago
Apr 13, 2021
|
Sell 1.73 M USD
|
DOYLE WILLIAM F
Executive Chairman |
- 8814
|
196.073 USD |
3 years ago
Apr 13, 2021
|
Sell 4.79 M USD
|
DOYLE WILLIAM F
Executive Chairman |
- 24338
|
197.003 USD |
3 years ago
Apr 13, 2021
|
Sell 2.69 M USD
|
DOYLE WILLIAM F
Executive Chairman |
- 13612
|
197.831 USD |
3 years ago
Apr 13, 2021
|
Sell 2.1 M USD
|
DOYLE WILLIAM F
Executive Chairman |
- 10563
|
198.977 USD |
3 years ago
Apr 13, 2021
|
Sell 866 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 4338
|
199.713 USD |
3 years ago
Apr 13, 2021
|
Sell 831 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 4125
|
201.546 USD |
3 years ago
Apr 13, 2021
|
Sell 887 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 4388
|
202.158 USD |
3 years ago
Apr 13, 2021
|
Sell 519 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 2555
|
203.253 USD |
3 years ago
Apr 13, 2021
|
Sell 403 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1972
|
204.277 USD |
3 years ago
Apr 13, 2021
|
Sell 329 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1600
|
205.431 USD |
3 years ago
Apr 13, 2021
|
Sell 265 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1284
|
206.352 USD |
3 years ago
Apr 13, 2021
|
Sell 935 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 4500
|
207.804 USD |
3 years ago
Apr 13, 2021
|
Sell 461 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 2200
|
209.343 USD |
3 years ago
Apr 13, 2021
|
Sell 110 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 521
|
210.181 USD |
3 years ago
Apr 13, 2021
|
Sell 127 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 600
|
211.276 USD |
3 years ago
Apr 13, 2021
|
Sell 320 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 1500
|
213.347 USD |
3 years ago
Apr 13, 2021
|
Sell 107 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 500
|
214.665 USD |
3 years ago
Apr 13, 2021
|
Sell 130 K USD
|
DOYLE WILLIAM F
Executive Chairman |
- 600
|
216.694 USD |
3 years ago
Apr 13, 2021
|
Sell 19.2 M USD
|
Danziger Asaf
Chief Executive Officer |
- 97973
|
196.3431 USD |
3 years ago
Apr 13, 2021
|
Sell 693 K USD
|
LEUNG GABRIEL
Director |
- 3500
|
198.01 USD |
3 years ago
Apr 13, 2021
|
Sell 500 K USD
|
LEUNG GABRIEL
Director |
- 2500
|
200 USD |
3 years ago
Apr 13, 2021
|
Sell 695 K USD
|
Benaim Ely
Chief Medical Officer |
- 3474
|
200 USD |
3 years ago
Mar 23, 2021
|
Sell 397 K USD
|
Weinberg Uri
Chief Science Officer |
- 2835
|
140 USD |
4 years ago
Feb 28, 2020
|
Sell 265 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 3670
|
72.215 USD |
3 years ago
Apr 01, 2021
|
Sell 1.06 M USD
|
DOYLE WILLIAM F
Executive Chairman |
- 7928
|
134.12 USD |
3 years ago
Mar 23, 2021
|
Sell 545 K USD
|
Weinberg Uri
Chief Science Officer |
- 3892
|
140 USD |
3 years ago
Mar 08, 2021
|
Sell 344 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 2627
|
130.806 USD |
3 years ago
Mar 09, 2021
|
Sell 462 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 3524
|
131.09 USD |
3 years ago
Mar 08, 2021
|
Sell 100 K USD
|
Cordova Ashley
Chief Financial Officer |
- 765
|
130.806 USD |
3 years ago
Mar 08, 2021
|
Sell 314 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2404
|
130.806 USD |
3 years ago
Mar 08, 2021
|
Sell 100 K USD
|
Leonard Frank X
Chief Development Officer |
- 765
|
130.806 USD |
3 years ago
Mar 08, 2021
|
Sell 393 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 3004
|
130.806 USD |
3 years ago
Mar 05, 2021
|
Sell 598 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 4550
|
131.53 USD |
3 years ago
Mar 05, 2021
|
Sell 384 K USD
|
Benaim Ely
Chief Medical Officer |
- 2918
|
131.53 USD |
3 years ago
Mar 04, 2021
|
Sell 530 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 3854
|
137.554 USD |
3 years ago
Mar 04, 2021
|
Sell 424 K USD
|
Longsworth Todd Christopher
General Counsel |
- 3084
|
137.554 USD |
3 years ago
Mar 04, 2021
|
Sell 78 K USD
|
Leonard Frank X
Chief Development Officer |
- 567
|
137.554 USD |
3 years ago
Mar 04, 2021
|
Sell 78 K USD
|
Cordova Ashley
Chief Financial Officer |
- 567
|
137.554 USD |
3 years ago
Mar 03, 2021
|
Sell 524 K USD
|
Benaim Ely
Chief Medical Officer |
- 3475
|
150.78 USD |
3 years ago
Mar 04, 2021
|
Sell 260 K USD
|
Benaim Ely
Chief Medical Officer |
- 1888
|
137.554 USD |
3 years ago
Mar 03, 2021
|
Sell 328 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 2174
|
150.78 USD |
3 years ago
Mar 04, 2021
|
Sell 366 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 2658
|
137.554 USD |
3 years ago
Mar 02, 2021
|
Sell 65.4 K USD
|
Leonard Frank X
Chief Development Officer |
- 430
|
152.053 USD |
3 years ago
Mar 02, 2021
|
Sell 65.1 K USD
|
Cordova Ashley
Chief Financial Officer |
- 428
|
152.053 USD |
3 years ago
Mar 02, 2021
|
Sell 364 K USD
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer |
- 2392
|
152.053 USD |
3 years ago
Mar 02, 2021
|
Sell 139 K USD
|
Shah Pritesh
Chief Commercial Officer |
- 912
|
152.053 USD |
3 years ago
Mar 02, 2021
|
Sell 358 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2355
|
152.053 USD |
3 years ago
Feb 22, 2021
|
Sell 1.14 M USD
|
Weinberg Uri
Chief Science Officer |
- 6500
|
175.5 USD |
3 years ago
Jan 15, 2021
|
Sell 419 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2499
|
167.761 USD |
3 years ago
Jan 15, 2021
|
Sell 135 K USD
|
Longsworth Todd Christopher
General Counsel |
- 800
|
168.804 USD |
3 years ago
Jan 15, 2021
|
Sell 365 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2148
|
169.76 USD |
3 years ago
Jan 15, 2021
|
Sell 473 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2761
|
171.184 USD |
3 years ago
Jan 15, 2021
|
Sell 1.74 M USD
|
Longsworth Todd Christopher
General Counsel |
- 10110
|
171.859 USD |
3 years ago
Jan 15, 2021
|
Sell 225 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1300
|
172.952 USD |
3 years ago
Jan 15, 2021
|
Sell 278 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1600
|
173.878 USD |
3 years ago
Jan 15, 2021
|
Sell 298 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1700
|
175.136 USD |
3 years ago
Jan 15, 2021
|
Sell 70.4 K USD
|
Longsworth Todd Christopher
General Counsel |
- 400
|
175.981 USD |
3 years ago
Jan 15, 2021
|
Sell 390 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2200
|
177.305 USD |
3 years ago
Jan 15, 2021
|
Sell 179 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1000
|
178.675 USD |
3 years ago
Jan 15, 2021
|
Sell 161 K USD
|
Longsworth Todd Christopher
General Counsel |
- 900
|
179.368 USD |
3 years ago
Jan 15, 2021
|
Sell 587 K USD
|
Longsworth Todd Christopher
General Counsel |
- 3500
|
167.774 USD |
3 years ago
Jan 15, 2021
|
Sell 305 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1800
|
169.194 USD |
3 years ago
Jan 15, 2021
|
Sell 432 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2542
|
169.933 USD |
3 years ago
Jan 15, 2021
|
Sell 827 K USD
|
Longsworth Todd Christopher
General Counsel |
- 4826
|
171.318 USD |
3 years ago
Jan 15, 2021
|
Sell 2.06 M USD
|
Longsworth Todd Christopher
General Counsel |
- 11985
|
171.903 USD |
3 years ago
Jan 15, 2021
|
Sell 294 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1700
|
173.1 USD |
3 years ago
Jan 15, 2021
|
Sell 436 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2502
|
174.063 USD |
3 years ago
Jan 15, 2021
|
Sell 386 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2200
|
175.279 USD |
3 years ago
Jan 15, 2021
|
Sell 70.5 K USD
|
Longsworth Todd Christopher
General Counsel |
- 400
|
176.215 USD |
3 years ago
Jan 15, 2021
|
Sell 504 K USD
|
Longsworth Todd Christopher
General Counsel |
- 2841
|
177.331 USD |
3 years ago
Jan 15, 2021
|
Sell 161 K USD
|
Longsworth Todd Christopher
General Counsel |
- 900
|
178.498 USD |
3 years ago
Jan 15, 2021
|
Sell 215 K USD
|
Longsworth Todd Christopher
General Counsel |
- 1200
|
179.301 USD |
3 years ago
Dec 21, 2020
|
Sell 102 K USD
|
Benaim Ely
Chief Medical Officer |
- 651
|
156.71 USD |
3 years ago
Dec 18, 2020
|
Sell 416 K USD
|
HILLEMAN JERYL L
Director |
- 2500
|
166.4 USD |
3 years ago
Dec 18, 2020
|
Sell 3.29 M USD
|
Danziger Asaf
Chief Executive Officer |
- 21207
|
155.232 USD |
3 years ago
Dec 18, 2020
|
Sell 3.36 M USD
|
Danziger Asaf
Chief Executive Officer |
- 21612
|
155.24 USD |
3 years ago
Dec 18, 2020
|
Sell 3.79 M USD
|
Danziger Asaf
Chief Executive Officer |
- 24286
|
156.091 USD |
3 years ago
Dec 18, 2020
|
Sell 3.9 M USD
|
Danziger Asaf
Chief Executive Officer |
- 24973
|
156.083 USD |
3 years ago
Dec 18, 2020
|
Sell 3.71 M USD
|
Danziger Asaf
Chief Executive Officer |
- 23601
|
157.007 USD |
3 years ago
Dec 18, 2020
|
Sell 3.87 M USD
|
Danziger Asaf
Chief Executive Officer |
- 24656
|
157.037 USD |
3 years ago
Dec 18, 2020
|
Sell 1.45 M USD
|
Danziger Asaf
Chief Executive Officer |
- 9183
|
158.094 USD |
3 years ago
Dec 18, 2020
|
Sell 1.59 M USD
|
Danziger Asaf
Chief Executive Officer |
- 10077
|
158.064 USD |
3 years ago
Dec 18, 2020
|
Sell 717 K USD
|
Danziger Asaf
Chief Executive Officer |
- 4500
|
159.323 USD |
3 years ago
Dec 18, 2020
|
Sell 763 K USD
|
Danziger Asaf
Chief Executive Officer |
- 4790
|
159.27 USD |
3 years ago
Dec 18, 2020
|
Sell 1.94 M USD
|
Danziger Asaf
Chief Executive Officer |
- 12092
|
160.25 USD |
3 years ago
Dec 18, 2020
|
Sell 1.87 M USD
|
Danziger Asaf
Chief Executive Officer |
- 11686
|
160.27 USD |
3 years ago
Dec 18, 2020
|
Sell 563 K USD
|
Danziger Asaf
Chief Executive Officer |
- 3500
|
160.994 USD |
3 years ago
Dec 18, 2020
|
Sell 647 K USD
|
Danziger Asaf
Chief Executive Officer |
- 4014
|
161.106 USD |
3 years ago
Dec 18, 2020
|
Sell 231 K USD
|
Danziger Asaf
Chief Executive Officer |
- 1426
|
162.173 USD |